List of Tables
Table 1. Global Nucleic Acid-based Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Antisense Oligonucleotides (ASO)
Table 3. Key Players of siRNA
Table 4. Key Players of mRNA
Table 5. Global Nucleic Acid-based Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Nucleic Acid-based Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Nucleic Acid-based Therapy Market Size by Region (US$ Million), 2021–2026
Table 8. Global Nucleic Acid-based Therapy Market Share by Region (2021–2026)
Table 9. Global Nucleic Acid-based Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Nucleic Acid-based Therapy Market Share by Region (2027–2032)
Table 11. Nucleic Acid-based Therapy Market Trends
Table 12. Nucleic Acid-based Therapy Market Drivers
Table 13. Nucleic Acid-based Therapy Market Challenges
Table 14. Nucleic Acid-based Therapy Market Restraints
Table 15. Global Nucleic Acid-based Therapy Revenue by Players (US$ Million), 2021–2026
Table 16. Global Nucleic Acid-based Therapy Market Share by Players (2021–2026)
Table 17. Global Top Nucleic Acid-based Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nucleic Acid-based Therapy Revenue, 2025
Table 18. Ranking of Global Top Nucleic Acid-based Therapy Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Nucleic Acid-based Therapy Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Nucleic Acid-based Therapy, Headquarters and Area Served
Table 21. Global Key Players of Nucleic Acid-based Therapy, Products and Applications
Table 22. Global Key Players of Nucleic Acid-based Therapy, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid-based Therapy Market Size by Type (US$ Million), 2021–2026
Table 25. Global Nucleic Acid-based Therapy Revenue Market Share by Type (2021–2026)
Table 26. Global Nucleic Acid-based Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Nucleic Acid-based Therapy Revenue Market Share by Type (2027–2032)
Table 28. Global Nucleic Acid-based Therapy Market Size by Application (US$ Million), 2021–2026
Table 29. Global Nucleic Acid-based Therapy Revenue Market Share by Application (2021–2026)
Table 30. Global Nucleic Acid-based Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Nucleic Acid-based Therapy Revenue Market Share by Application (2027–2032)
Table 32. North America Nucleic Acid-based Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2021–2026
Table 34. North America Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Nucleic Acid-based Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Nucleic Acid-based Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Nucleic Acid-based Therapy Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Nucleic Acid-based Therapy Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Nucleic Acid-based Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Nucleic Acid-based Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Nucleic Acid-based Therapy Market Size by Country (US$ Million), 2027–2032
Table 47. Sarepta Therapeutics Company Details
Table 48. Sarepta Therapeutics Business Overview
Table 49. Sarepta Therapeutics Nucleic Acid-based Therapy Product
Table 50. Sarepta Therapeutics Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 51. Sarepta Therapeutics Recent Development
Table 52. Ionis Pharmaceuticals Company Details
Table 53. Ionis Pharmaceuticals Business Overview
Table 54. Ionis Pharmaceuticals Nucleic Acid-based Therapy Product
Table 55. Ionis Pharmaceuticals Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 56. Ionis Pharmaceuticals Recent Development
Table 57. Alnylam Company Details
Table 58. Alnylam Business Overview
Table 59. Alnylam Nucleic Acid-based Therapy Product
Table 60. Alnylam Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 61. Alnylam Recent Development
Table 62. Biogen Company Details
Table 63. Biogen Business Overview
Table 64. Biogen Nucleic Acid-based Therapy Product
Table 65. Biogen Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 66. Biogen Recent Development
Table 67. Nippon Shinyaku Company Details
Table 68. Nippon Shinyaku Business Overview
Table 69. Nippon Shinyaku Nucleic Acid-based Therapy Product
Table 70. Nippon Shinyaku Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 71. Nippon Shinyaku Recent Development
Table 72. Sobi Company Details
Table 73. Sobi Business Overview
Table 74. Sobi Nucleic Acid-based Therapy Product
Table 75. Sobi Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 76. Sobi Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Nucleic Acid-based Therapy Product
Table 80. Novartis Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 81. Novartis Recent Development
Table 82. BioNTech Company Details
Table 83. BioNTech Business Overview
Table 84. BioNTech Nucleic Acid-based Therapy Product
Table 85. BioNTech Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 86. BioNTech Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Nucleic Acid-based Therapy Product
Table 90. Pfizer Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 91. Pfizer Recent Development
Table 92. Moderna Therapeutics Company Details
Table 93. Moderna Therapeutics Business Overview
Table 94. Moderna Therapeutics Nucleic Acid-based Therapy Product
Table 95. Moderna Therapeutics Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 96. Moderna Therapeutics Recent Development
Table 97. Jazz Pharmaceuticals Company Details
Table 98. Jazz Pharmaceuticals Business Overview
Table 99. Jazz Pharmaceuticals Nucleic Acid-based Therapy Product
Table 100. Jazz Pharmaceuticals Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 101. Jazz Pharmaceuticals Recent Development
Table 102. CureVac Company Details
Table 103. CureVac Business Overview
Table 104. CureVac Nucleic Acid-based Therapy Product
Table 105. CureVac Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 106. CureVac Recent Development
Table 107. Regulus Therapeutics Company Details
Table 108. Regulus Therapeutics Business Overview
Table 109. Regulus Therapeutics Nucleic Acid-based Therapy Product
Table 110. Regulus Therapeutics Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 111. Regulus Therapeutics Recent Development
Table 112. ProQR Company Details
Table 113. ProQR Business Overview
Table 114. ProQR Nucleic Acid-based Therapy Product
Table 115. ProQR Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 116. ProQR Recent Development
Table 117. Secarna Company Details
Table 118. Secarna Business Overview
Table 119. Secarna Nucleic Acid-based Therapy Product
Table 120. Secarna Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 121. Secarna Recent Development
Table 122. MiNA Therapeutics Company Details
Table 123. MiNA Therapeutics Business Overview
Table 124. MiNA Therapeutics Nucleic Acid-based Therapy Product
Table 125. MiNA Therapeutics Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 126. MiNA Therapeutics Recent Development
Table 127. Sylentis Company Details
Table 128. Sylentis Business Overview
Table 129. Sylentis Nucleic Acid-based Therapy Product
Table 130. Sylentis Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 131. Sylentis Recent Development
Table 132. Arrowhead Company Details
Table 133. Arrowhead Business Overview
Table 134. Arrowhead Nucleic Acid-based Therapy Product
Table 135. Arrowhead Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 136. Arrowhead Recent Development
Table 137. Silence Therapeutics Company Details
Table 138. Silence Therapeutics Business Overview
Table 139. Silence Therapeutics Nucleic Acid-based Therapy Product
Table 140. Silence Therapeutics Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 141. Silence Therapeutics Recent Development
Table 142. Dicerna Company Details
Table 143. Dicerna Business Overview
Table 144. Dicerna Nucleic Acid-based Therapy Product
Table 145. Dicerna Revenue in Nucleic Acid-based Therapy Business (US$ Million), 2021–2026
Table 146. Dicerna Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Nucleic Acid-based Therapy Picture
Figure 2. Global Nucleic Acid-based Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Nucleic Acid-based Therapy Market Share by Type: 2025 vs 2032
Figure 4. Antisense Oligonucleotides (ASO) Features
Figure 5. siRNA Features
Figure 6. mRNA Features
Figure 7. Global Nucleic Acid-based Therapy Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Nucleic Acid-based Therapy Market Share by Application: 2025 vs 2032
Figure 9. Neuromuscular Diseases Case Studies
Figure 10. hATTR Case Studies
Figure 11. COVID-19 Case Studies
Figure 12. Other Case Studies
Figure 13. Nucleic Acid-based Therapy Report Years Considered
Figure 14. Global Nucleic Acid-based Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Nucleic Acid-based Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Nucleic Acid-based Therapy Market Share by Region: 2025 vs 2032
Figure 17. Global Nucleic Acid-based Therapy Market Share by Players in 2025
Figure 18. Global Nucleic Acid-based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid-based Therapy Revenue in 2025
Figure 20. North America Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Nucleic Acid-based Therapy Market Share by Country (2021–2032)
Figure 22. United States Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Nucleic Acid-based Therapy Market Share by Country (2021–2032)
Figure 26. Germany Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Nucleic Acid-based Therapy Market Share by Region (2021–2032)
Figure 34. China Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Nucleic Acid-based Therapy Market Share by Country (2021–2032)
Figure 42. Mexico Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Nucleic Acid-based Therapy Market Share by Country (2021–2032)
Figure 46. Israel Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Nucleic Acid-based Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 51. Alnylam Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 52. Biogen Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 53. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 54. Sobi Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 55. Novartis Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 56. BioNTech Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 57. Pfizer Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 58. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 60. CureVac Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 61. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 62. ProQR Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 63. Secarna Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 64. MiNA Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 65. Sylentis Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 66. Arrowhead Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 67. Silence Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 68. Dicerna Revenue Growth Rate in Nucleic Acid-based Therapy Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
